Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Pathology of Charcot-Marie-Tooth Disease].
Biological role of Toll-like receptor-4 in the brain.
Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.
A novel automated segmentation method for retinal layers in OCT images proves retinal degeneration after optic neuritis.
A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Signs of myelin impairment in cerebrospinal fluid after osmotic opening of the blood-brain barrier in rats.
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
No Geographic Correlation between Lyme Disease and Death Due to 4 Neurodegenerative Disorders, United States, 2001-2010.
Ranking of Disease-Modifying Therapies for Multiple Sclerosis.
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.
Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol - studies in BV-2 microglia and encephalitogenic T cells.
Validation of Social Media Analysis for Outcomes Research: Identification of Drivers of Switches between oral and Injectable Therapies for Multiple Sclerosis.
In Vivo Fate Imaging of Intracerebral Stem Cell Grafts in Mouse Brain.
Regulation of Immunity by Butyrophilins.
Changes of CXCL12, CXCL14 and PDGF levels in the brain of patients with idiopathic demyelinating optic neuritis and neuromyelitis optica.
Haplotype-based approach to known MS-associated regions increases the amount of explained risk.
Three decades of drift: the misdiagnosis of predominantly neuropsychiatric multiple sclerosis.
Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center.
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Life-Span.
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.
Pages
« first
‹ previous
…
641
642
643
644
645
646
647
648
649
…
next ›
last »